New migraine drug shows promise in clinical trial

When migraine sufferers were given ubrogepant versus a placebo, they noticed a significant reduction in pain after two hours.

Latest LiveNOW Stories

From the Archives

Consumer & Money

Science & Tech

Police Chases

Weather Across the Country